Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

BACKGROUND: Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data. METHODS: In a multicenter, single-blind, noninfer...

Full description

Saved in:
Bibliographic Details
Format: Artigo
Language:Inglês
Published: 2011
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3157322/
https://ncbi.nlm.nih.gov/pubmed/21526923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1102673
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items